Is VUG a Good ETF to Buy?
For the last few years, earnings growth from the tech…
Sell
34
MLSS Quote, Financials, Valuation and Earnings
Last price:
$0.94
Seasonality move
:
-5.1%
Day range:
$0.88 - $0.96
52-week range:
$0.54 - $1.39
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
8.28x
P/B ratio:
10.12x
Volume:
70.8K
Avg. volume:
105K
1-year change:
27.59%
Market cap:
$73M
Revenue:
$9.8M
EPS (TTM):
-$0.07
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Milestone Scientific has 126.59% upside to fair value with a price target of -- per share.
MLSS vs. S&P 500
-
Over the past 5 trading days, Milestone Scientific has underperformed the S&P 500 by -12.99% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Milestone Scientific does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Milestone Scientific has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Milestone Scientific reported revenues of $2.5M.
Earnings Growth
-
Milestone Scientific has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Milestone Scientific reported earnings per share of -$0.02.
Enterprise value:
68.3M
EV / Invested capital:
--
Price / LTM sales:
8.28x
EV / EBIT:
--
EV / Revenue:
7.69x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-25.62x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$6.4M
Return On Assets:
-40.87%
Net Income Margin (TTM):
-52.01%
Return On Equity:
-61.33%
Return On Invested Capital:
-61.33%
Operating Margin:
-58.44%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $9.4M | $9.8M | $8.9M | $2.1M | $2.5M | |
| Gross Profit | $5.6M | $6.4M | $6.4M | $1.5M | $1.8M | |
| Operating Income | -$8.4M | -$7.1M | -$6.7M | -$1.5M | -$1.5M | |
| EBITDA | -$8.2M | -$7M | -$6.6M | -$1.5M | -$1.4M | |
| Diluted EPS | -$0.12 | -$0.09 | -$0.07 | -$0.02 | -$0.02 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $18.9M | $19.2M | $14.5M | $10M | $10.7M | |
| Total Assets | $19.9M | $20.1M | $15.3M | $10.6M | $11.2M | |
| Current Liabilities | $3.5M | $3.5M | $3.7M | $3.3M | $3.8M | |
| Total Liabilities | $4.1M | $4M | $4.1M | $3.6M | $4M | |
| Total Equity | $15.8M | $16M | $11.2M | $7M | $7.2M | |
| Total Debt | $276.2K | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$5.3M | -$5.2M | -$2.7M | -$1.1M | -$973.9K | |
| Cash From Investing | $500 | -$2.5M | $2.5M | -$475.5K | -- | |
| Cash From Financing | $667.5K | -$8.5K | $2.8M | -$2.2K | -$2.6K | |
| Free Cash Flow | -$5.3M | -$5.2M | -$2.7M | -$1.1M | -$973.9K | |
MLSS
Sector
Market Cap
$73M
$36.4M
Price % of 52-Week High
67.34%
45.1%
Dividend Yield
0%
0%
Shareholder Yield
-3.91%
-0.74%
1-Year Price Total Return
27.59%
-39.83%
Beta (5-Year)
1.409
0.773
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$1.01
200-day SMA
Buy
Level
$0.92
Bollinger Bands (100)
Sell
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Sell
Level
$1.08
Relative Strength Index (RSI14)
Sell
Level
42.04
ADX Line
Neutral
Level
0
Williams %R
Buy
Level
-85.0891
50-day SMA
Sell
Level
$1.11
MACD (12, 26)
Sell
Level
-0.04
25-day Aroon Oscillator
Sell
Level
-92
On Balance Volume
Neutral
Level
--
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-6.2215)
Sell
CA Score
(Annual)
Level (-1.6688)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (5.4769)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (7)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Milestone Scientific Inc is engaged in pioneering proprietary, technological systems, and solutions for the medical and dental markets. It develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetic. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. In addition, the company provides The Wand, a handpiece that allows dentists to provide painless injections for virtually various dental procedures, including routine cleanings and fillings, as well as implants, root canals, and crowns. The Company conducts its business through two reportable segments: Dental and Medical. Geographically all the operations of the firm function through the region of the U.S.
Stock Forecast FAQ
In the current month, MLSS has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MLSS average analyst price target in the past 3 months is --.
-
Where Will Milestone Scientific Stock Be In 1 Year?
According to analysts, the consensus estimate is that Milestone Scientific share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Milestone Scientific?
Analysts are divided on their view about Milestone Scientific share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Milestone Scientific is a Sell and believe this share price will drop from its current level to --.
-
What Is Milestone Scientific's Price Target?
The price target for Milestone Scientific over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is MLSS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Milestone Scientific is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of MLSS?
You can purchase shares of Milestone Scientific via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Milestone Scientific shares.
-
What Is The Milestone Scientific Share Price Today?
Milestone Scientific was last trading at $0.94 per share. This represents the most recent stock quote for Milestone Scientific. Yesterday, Milestone Scientific closed at $0.94 per share.
-
How To Buy Milestone Scientific Stock Online?
In order to purchase Milestone Scientific stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Does Intel Stock Have Room to Grow?
Intel Corporation (NASDAQ:INTC)’s recent innovations, Xeon 6 SoC and Xeon®…
Is Walmart the Largest Retailer in the World?
For many years, Walmart (NYSE:WMT) has been the world’s largest…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Sell
44
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
45
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Sell
50
GH alert for Mar 12
Guardant Health [GH] is up 1.1% over the past day.
Sell
44
TER alert for Mar 12
Teradyne [TER] is down 0.36% over the past day.
Buy
57
LMB alert for Mar 12
Limbach Holdings [LMB] is down 4.39% over the past day.
